Atypical antipsychotic lurasidone newly approved for schizophrenia
Meta-analysis finds antipsychotics superior to mood stabilizers in acute mania
AERS detects interaction between paroxetine and pravastatin
Switching to an antipsychotic with lower metabolic risk
Raloxifene adjunctive to antipsychotics in postmenopausal schizophrenia
News Notes
Immediate-release oxybutynin for clozapine-induced sialorrhea
From the FDA